Novo Nordisk A/S (NVO)
42.79
+0.60
(+1.42%)
USD |
NYSE |
Jun 10, 16:00
42.71
-0.08
(-0.19%)
After-Hours: 20:00
Novo Nordisk 1 Year Total Returns (Daily) : -41.53% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | -41.53% |
| June 08, 2026 | -42.52% |
| June 05, 2026 | -38.16% |
| June 04, 2026 | -36.49% |
| June 03, 2026 | -38.06% |
| June 02, 2026 | -38.37% |
| June 01, 2026 | -35.54% |
| May 29, 2026 | -31.38% |
| May 28, 2026 | -30.62% |
| May 27, 2026 | -33.86% |
| May 26, 2026 | -31.39% |
| May 22, 2026 | -31.03% |
| May 21, 2026 | -31.93% |
| May 20, 2026 | -30.89% |
| May 19, 2026 | -30.91% |
| May 18, 2026 | -28.06% |
| May 15, 2026 | -29.27% |
| May 14, 2026 | -25.64% |
| May 13, 2026 | -24.72% |
| May 12, 2026 | -27.44% |
| May 11, 2026 | -26.22% |
| May 08, 2026 | -25.71% |
| May 07, 2026 | -29.10% |
| May 06, 2026 | -27.81% |
| May 05, 2026 | -32.11% |
| Date | Value |
|---|---|
| May 04, 2026 | -32.95% |
| May 01, 2026 | -30.05% |
| April 30, 2026 | -33.56% |
| April 29, 2026 | -35.34% |
| April 28, 2026 | -31.25% |
| April 27, 2026 | -30.60% |
| April 24, 2026 | -31.26% |
| April 23, 2026 | -34.29% |
| April 22, 2026 | -31.66% |
| April 21, 2026 | -29.33% |
| April 20, 2026 | -27.15% |
| April 17, 2026 | -27.04% |
| April 16, 2026 | -31.93% |
| April 15, 2026 | -33.82% |
| April 14, 2026 | -37.76% |
| April 13, 2026 | -38.64% |
| April 10, 2026 | -35.90% |
| April 09, 2026 | -39.85% |
| April 08, 2026 | -36.15% |
| April 07, 2026 | -39.35% |
| April 06, 2026 | -38.69% |
| April 02, 2026 | -43.33% |
| April 01, 2026 | -43.92% |
| March 31, 2026 | -44.66% |
| March 30, 2026 | -45.87% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 27.83% |
| GSK Plc | 30.20% |
| Johnson & Johnson | 56.49% |
| Eli Lilly & Co. | 48.98% |
| Merck & Co., Inc. | 56.24% |